THE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST

πŸ‡¬πŸ‡§United Kingdom
Ownership
-
Established
1991-01-01
Employees
-
Market Cap
-
Website
http://www.clatterbridgecc.nhs.uk/
Clinical Trials
Related News

Phase II Study of the Use of Neoadjuvant Cabazitaxel With Hormonal Treatment in Patients Operable Prostate Cancer, Assess the Efficacy and Toxicity of Cabazitaxel, and Explore Potential Predictive and Prognostic Markers of Clinical Outcome

Phase 2
Not yet recruiting
Conditions
Prostate Cancer
Interventions
Drug: Cabazitaxel
First Posted Date
2020-11-10
Last Posted Date
2021-01-05
Lead Sponsor
The Clatterbridge Cancer Centre NHS Foundation Trust
Target Recruit Count
120
Registration Number
NCT04622761

CCP Cancer UK Companion Study

Conditions
Cancer
Covid19
First Posted Date
2020-10-26
Last Posted Date
2021-01-05
Lead Sponsor
The Clatterbridge Cancer Centre NHS Foundation Trust
Target Recruit Count
9000
Registration Number
NCT04603105

A Phase II Clinical Trial of Cediranib and Olaparib Maintenance in Advanced Recurrent Cervical Cancer

Phase 2
Conditions
Cervical Cancer
Interventions
Drug: Cediranib, Olaparib
First Posted Date
2020-07-27
Last Posted Date
2020-07-27
Lead Sponsor
The Clatterbridge Cancer Centre NHS Foundation Trust
Target Recruit Count
108
Registration Number
NCT04487587
Locations
πŸ‡¬πŸ‡§

Clatterbridge Cancer Centre, Wirral, United Kingdom

Magnetic Resonance Imaging for Lung Radiotherapy

First Posted Date
2020-02-19
Last Posted Date
2021-01-05
Lead Sponsor
The Clatterbridge Cancer Centre NHS Foundation Trust
Target Recruit Count
15
Registration Number
NCT04275921
Locations
πŸ‡¬πŸ‡§

Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, United Kingdom

Investigation of an Abdominal Compression Device

First Posted Date
2020-02-17
Last Posted Date
2021-01-05
Lead Sponsor
The Clatterbridge Cancer Centre NHS Foundation Trust
Target Recruit Count
30
Registration Number
NCT04270890
Locations
πŸ‡¬πŸ‡§

Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, United Kingdom

Nivolumab in Combination With TACE/TAE for Patients With Intermediate Stage HCC

First Posted Date
2020-02-13
Last Posted Date
2020-07-16
Lead Sponsor
The Clatterbridge Cancer Centre NHS Foundation Trust
Target Recruit Count
522
Registration Number
NCT04268888
Locations
πŸ‡¬πŸ‡§

University of Liverpool, Liverpool, United Kingdom

CA209-891: Neoadjuvant and Adjuvant Nivolumab as Immune Checkpoint Inhibition in Oral Cavity Cancer

First Posted Date
2018-10-26
Last Posted Date
2021-01-05
Lead Sponsor
The Clatterbridge Cancer Centre NHS Foundation Trust
Target Recruit Count
21
Registration Number
NCT03721757
Locations
πŸ‡¬πŸ‡§

Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, United Kingdom

Acelarin First Line Randomised Pancreatic Study

First Posted Date
2018-08-01
Last Posted Date
2019-10-29
Lead Sponsor
The Clatterbridge Cancer Centre NHS Foundation Trust
Target Recruit Count
328
Registration Number
NCT03610100
Locations
πŸ‡¬πŸ‡§

Cancer Research UK Liverpool Cancer Trials Unit, Liverpool, Merseyside, United Kingdom

Cardiopulmonary Exercise Testing: An Assessment of Patients Fitness for Palliative Chemotherapy for Pancreatic Cancer

First Posted Date
2017-07-12
Last Posted Date
2021-01-05
Lead Sponsor
The Clatterbridge Cancer Centre NHS Foundation Trust
Target Recruit Count
100
Registration Number
NCT03215459

BIOPROP20: Biologically Optimised IMRT for Prostate Radiotherapy Hypofractionated Radiotherapy With Intra-prostatic Boosts to Tumour Nodules in Men With Intermediate and High Risk Prostate Cancer

Not Applicable
Completed
Conditions
Prostate Cancer
Interventions
Radiation: Hypofractionated IMRT boost Radiotherapy
First Posted Date
2014-04-29
Last Posted Date
2019-10-29
Lead Sponsor
The Clatterbridge Cancer Centre NHS Foundation Trust
Target Recruit Count
55
Registration Number
NCT02125175
Locations
πŸ‡¬πŸ‡§

The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, Wirral, United Kingdom

Β© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy